Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Breast Cancer

Free Subscription 11.05.2026 1 AJR Am J Roentgenol 1 Am J Epidemiol 1 Am J Pathol 1 Ann Oncol 2 Ann Surg Oncol 2 BMC Cancer 1 Breast Cancer (Auckl) 4 Breast Cancer (Dove Med Press) 5 Breast Cancer Res 2 Breast Cancer Res Treat 2 Cancer Epidemiol Biomarkers Prev 1 Cancer Lett 2 Clin Breast Cancer 1 Eur J Cancer 2 Eur J Surg Oncol 2 Eur Radiol 2 Int J Cancer 1 J Biol Chem 2 J Clin Oncol 2 J Natl Cancer Inst 1 J Surg Oncol 1 Lancet 1 NPJ Breast Cancer 1 Oncology (Williston Park) 7 PLoS One 1 Proc Natl Acad Sci U S A 1 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. SCHOPF C, Domchek SM, Tice JA, Eby PR, et al
   Risk Stratification for Breast Cancer Screening: AJR Expert Panel Narrative Review.
   AJR Am J Roentgenol. 2026 May 6. doi: 10.2214/AJR.26.34641.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

2. SUGER AH, Chen H, Haas CB, Fan S, et al
   Interactions between genetic and epidemiological factors influencing mammographic density.
   Am J Epidemiol. 2026;195:1231-1241.
   PubMed         Abstract available
   
   

   
   Am J Pathol

3. HLADIK C, Sekhri M, Cen HH, Elayapillai SP, et al
   Spatially Resolved Obesity-Driven Molecular Changes in Early Breast Cancer.
   Am J Pathol. 2026 Apr 30:S0002-9440(26)00124.
   PubMed         Abstract available
   
   

   
   Ann Oncol

4. GARRIGOS L, Ruiz-Borrego M, Perez-Garcia JM, Guerrero-Zotano A, et al
   A chemotherapy-free, pathological response-adapted strategy using trastuzumab-pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study.
   Ann Oncol. 2026 May 6:S0923-7534(26)00040-2. doi: 10.1016/j.annonc.2026.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

5. GRAHAM-STEPHENSON A, Fanning CE, Geven EL, Migyanka F, et al
   ASO Visual Abstract: Geographic Differences in Patient Experience after a Diagnosis of Lobular Breast Cancer.
   Ann Surg Oncol. 2026 May 7. doi: 10.1245/s10434-026-19635.
   PubMed        
   
   
6. MULLER M, Heil J, Pfob A, Cai L, et al
   Predictive Value of Routine Imaging for the Diagnosis of Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
   Ann Surg Oncol. 2026 May 4. doi: 10.1245/s10434-026-19670.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. AKPALAMUT D, Ellez HI, Atag E, Aktepe OH, et al
   Prognostic factors and survival in elderly breast cancer patients: roles of age, stage and inflammatory markers.
   BMC Cancer. 2026 May 7. doi: 10.1186/s12885-026-16142.
   PubMed         Abstract available
   
   
8. LI H, Chen Y, Guo G, Luo Q, et al
   PPP4C: a potential molecular marker and therapeutic target in thyroid cancer and triple-negative breast cancer.
   BMC Cancer. 2026 May 4. doi: 10.1186/s12885-026-16083.
   PubMed         Abstract available
   
   

   
   Breast Cancer (Auckl)

9. SANG W, Shi Y, Wang B, Zhang L, et al
   Rapid Hemostasis and Significant Tumor Regression in Ulcerative Breast Cancer Via Combined Modified Lattice Radiotherapy and Systemic Therapy: A Case Report.
   Breast Cancer (Auckl). 2026;20:11782234261441378.
   PubMed         Abstract available
   
   

   
   Breast Cancer (Dove Med Press)

10. ZHAO J, Gou Y, Wang Y, Li Y, et al
    Multi-Omics Characterization of ABHD12 Across Pan-Cancer and Validation of Its Role in Promoting Proliferation and Metastasis in Breast Cancer.
    Breast Cancer (Dove Med Press). 2026;18:554836.
    PubMed         Abstract available
    
    
11. PARK KT, Lee NR, Jeong YJ
    Clinical Relevance of USP44 Expression and DNA Methylation Status in Breast Cancer Cell Lines, Tumor Tissues, and Circulating Tumor DNA.
    Breast Cancer (Dove Med Press). 2026;18:599533.
    PubMed         Abstract available
    
    
12. PAN H, Huang Z, Li A, Li M, et al
    Genetic Correlation of miR-423 Polymorphism rs8067576 with Progression and Prognosis of Triple-Negative Breast Cancer.
    Breast Cancer (Dove Med Press). 2026;18:577378.
    PubMed         Abstract available
    
    
13. OBEAGU EI
    Hematologic Glyco-Signatures: Emerging Blood-Based Sugar Codes Linked to Hyper-Aggressive Breast Cancer.
    Breast Cancer (Dove Med Press). 2026;18:603801.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

14. SAUNDERS AAE, Mouchemore KA, Vojtech L, James LS, et al
    Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling.
    Breast Cancer Res. 2026 May 7. doi: 10.1186/s13058-026-02296.
    PubMed         Abstract available
    
    
15. SUN L, Wang Z, Zhang W, Yang Y, et al
    Multimodal radiomics incorporating intratumoral heterogeneity for prognostic assessment of metastatic outcomes in invasive breast cancer.
    Breast Cancer Res. 2026 May 7. doi: 10.1186/s13058-026-02287.
    PubMed         Abstract available
    
    
16. SETH S, Yam C, Huo L, Lim B, et al
    The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancer.
    Breast Cancer Res. 2026 May 6. doi: 10.1186/s13058-026-02290.
    PubMed         Abstract available
    
    
17. DE OLIVEIRA ANDRADE F, Staley C, Jin L, Ozgul-Onal M, et al
    Gut microbiome modulates breast cancer risk in socially isolated mice.
    Breast Cancer Res. 2026 May 2. doi: 10.1186/s13058-026-02292.
    PubMed         Abstract available
    
    
18. CRUZ-REYES N, Liang H, Stallings-Mann M, Pacheco-Spann L, et al
    Multi?scale immune and spatial profiling of sclerosing adenosis and surrounding breast tissue identifies an immune?cold field phenotype associated with breast cancer risk.
    Breast Cancer Res. 2026 May 2. doi: 10.1186/s13058-026-02293.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

19. RAVANI LV, Wander SA, Kok M, McCann K, et al
    Long-term outcomes in triple-negative breast cancer after a pathologic complete response: does the type of neoadjuvant therapy matter?
    Breast Cancer Res Treat. 2026;217:28.
    PubMed         Abstract available
    
    
20. MATUSZ-FISHER A, Livasy CA, Donahue EE, Hadzikadic-Gusic L, et al
    Racial differences in pathologic complete response rate and clinical outcomes following neoadjuvant chemotherapy for breast cancer.
    Breast Cancer Res Treat. 2026;217:29.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

21. LU XA, Howard SP, McCullough LE, Williams BM, et al
    Examining the Role of the Social Vulnerability Index in the Association Between Race/Ethnicity with Breast Cancer Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2026 May 5. doi: 10.1158/1055-9965.EPI-25-1088
    PubMed         Abstract available
    
    
22. LAWRENCE KG, Woo JMP, O'Brien KM, Sandler DP, et al
    Neighborhood Disadvantage and Breast Cancer among Women Living in the United States.
    Cancer Epidemiol Biomarkers Prev. 2026.
    PubMed         Abstract available
    
    

    
    Cancer Lett

23. NAND PK, Croucher DR, Khachigian LM
    Challenges in Triple Negative Breast Cancer Treatment and Therapeutic Potential of the Mitogen Activated Protein Kinase Pathway.
    Cancer Lett. 2026 May 2:218556. doi: 10.1016/j.canlet.2026.218556.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

24. PEG V, Burgues O, Ruiz I, Carcedo D, et al
    A Decade of Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer in Spain: A Comprehensive Real-World Data Analysis (2013-2023).
    Clin Breast Cancer. 2026 Apr 9:S1526-8209(26)00061.
    PubMed         Abstract available
    
    
25. YU Y, Dai C, Ling R
    The Association Between Diet-Physical Activity Patterns and Breast Cancer: A Cross-Sectional Study From NHANES 2007 to 2018.
    Clin Breast Cancer. 2026;26:32-43.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

26. CORSO G, Andreon C, La Vecchia C, Bottazzoli EI, et al
    Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status.
    Eur J Cancer. 2026;239:116692.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

27. LUCOCQ J, Mitchell S, Potter S, Elder K, et al
    Targeted axillary dissection in the primary surgery setting for node-positive breast cancer: A systematic review.
    Eur J Surg Oncol. 2026;52:111852.
    PubMed         Abstract available
    
    
28. TAMMINEN A, Lintunen R, Aaltonen RI
    Capsulectomy for chronic encapsulated seroma after breast cancer surgery: prone to complications and limited efficacy.
    Eur J Surg Oncol. 2026;52:111866.
    PubMed         Abstract available
    
    

    
    Eur Radiol

29. YU W, Chen P, Chai S, Ding W, et al
    Deep learning model for noninvasive prediction of Ki-67 expression and prognostic stratification in breast cancer: a multicenter retrospective study.
    Eur Radiol. 2026 May 7. doi: 10.1007/s00330-025-12203.
    PubMed         Abstract available
    
    
30. MARTINIUSSEN MA, Bergan MB, Kristiansen MU, Moshina N, et al
    High risk score of breast cancer by artificial intelligence (AI) on screening mammograms: a review of negative and cancer cases.
    Eur Radiol. 2026 May 6. doi: 10.1007/s00330-026-12579.
    PubMed         Abstract available
    
    

    
    Int J Cancer

31. MAES-CARBALLO M, de-la-Puente-Mota N, Sampol-Ramirez L, Martinez-Martinez C, et al
    Integrating Shared Decision-Making Into Breast Cancer Postmastectomy Reconstruction: A Systematic Review of Evidence, Barriers, and Real-World Implementation.
    Int J Cancer. 2026 May 7. doi: 10.1002/ijc.70493.
    PubMed         Abstract available
    
    
32. BAR M, Widlak W, Vydra N
    Targeting ERalpha Coregulator Networks to Overcome Endocrine Resistance in ER+ Breast Cancer.
    Int J Cancer. 2026 May 4. doi: 10.1002/ijc.70522.
    PubMed         Abstract available
    
    

    
    J Biol Chem

33. PU P, Jin Y, Zhang S, Xu Y, et al
    A Tri-specific EGFR/cMet/VEGF Antibody Demonstrates Potent Multi-Mechanistic Activity in Preclinical Triple-Negative Breast Cancer Models.
    J Biol Chem. 2026 Apr 30:113100. doi: 10.1016/j.jbc.2026.113100.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

34. SHI H, Huang J, Chen X, Shen K, et al
    Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection.
    J Clin Oncol. 2026 May 4:JCO2600605. doi: 10.1200/JCO-26-00605.
    PubMed        
    
    
35. KOMATA R, Ando K, Shimomura A, Shimizu C, et al
    Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection.
    J Clin Oncol. 2026 May 4:JCO2600140. doi: 10.1200/JCO-26-00140.
    PubMed        
    
    

    
    J Natl Cancer Inst

36. LI R, Liu Z, Zhang S, Wu X, et al
    RE: Tamoxifen therapy benefit in luminal a and B breast cancer with 20-year follow-up.
    J Natl Cancer Inst. 2026 May 3:djag132. doi: 10.1093.
    PubMed        
    
    
37. SHI H, Chen S, Tang Y
    RE: Tamoxifen therapy benefit in luminal a and B breast cancer with 20-year follow-up.
    J Natl Cancer Inst. 2026 May 3:djag131. doi: 10.1093.
    PubMed        
    
    

    
    J Surg Oncol

38. PUIRAS T, Juhanoja E, Tamminen A
    Omission of Sentinel Lymph Node Biopsy in Breast Cancer: A Real-World Validation of the Patient Populations of the SOUND and INSEMA Trials.
    J Surg Oncol. 2026 May 6. doi: 10.1002/jso.70256.
    PubMed         Abstract available
    
    

    
    Lancet

39. 
    Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials.
    Lancet. 2026;407:1699-1711.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

40. ALENEZI WM, Recio N, Fierheller CT, Serruya C, et al
    Co-occurring rare germline DNA repair gene variants in BRCA1/BRCA2 implicated hereditary breast cancer families.
    NPJ Breast Cancer. 2026 May 5. doi: 10.1038/s41523-026-00956.
    PubMed         Abstract available
    
    

    
    Oncology (Williston Park)

41. DREIDI M, Asmar I, Ayayda M
    Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.
    Oncology (Williston Park). 2026;40:165-171.
    PubMed         Abstract available
    
    

    
    PLoS One

42. HWANGBO S, Choi Y, Ryu JY
    Development of predictive models for the prognosis of triple-negative breast cancer using multiple transcriptomic analyses.
    PLoS One. 2026;21:e0348414.
    PubMed         Abstract available
    
    
43. 
    Retraction: Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.
    PLoS One. 2026;21:e0348849.
    PubMed        
    
    
44. SIAME C, Ofori B, Paemka LA, Danquah KO, et al
    In silico evaluation of garlic-derived organosulfur compounds as multi-target inhibitors of breast cancer biomarkers.
    PLoS One. 2026;21:e0348369.
    PubMed         Abstract available
    
    
45. RAJAMOHAN HR, Xu Y, Zhu W, Kijowski R, et al
    Robust disease prognosis via diagnostic knowledge preservation: A sequential learning approach.
    PLoS One. 2026;21:e0344600.
    PubMed         Abstract available
    
    
46. SASAKI T, Torii S
    Node properties of biomarkers within the protein-protein interaction network derived from breast cancer-associated genes.
    PLoS One. 2026;21:e0347551.
    PubMed         Abstract available
    
    
47. ALY IBRAHIM AA, Darwish MY, El-Farargy SH, Saad NE, et al
    Exploring socio-demographic determinants of breast self-examination practices among Jordanian women: insights from the 2023 population-based survey.
    PLoS One. 2026;21:e0347331.
    PubMed         Abstract available
    
    
48. WALYELDEEN AA, Mohamed G, Taha SN, Gameel AM, et al
    Plasma small-extracellular vesicles' proteomic signature in neoadjuvant chemotherapy-naive breast cancer patients.
    PLoS One. 2026;21:e0348500.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

49. HAN YJ, Zhang J, Shariff M, Wu S, et al
    Regulation of antiviral and antitumor immunity by the BRCA1 pseudogene in human cancers.
    Proc Natl Acad Sci U S A. 2026;123:e2528911123.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

50. RAVINDRA S, Cafferty FH, Harris E, Gulliford S, et al
    Factors associated with arm swelling in patients undergoing surgery and radiotherapy for breast cancer within the FAST-Forward trial nodal sub-study.
    Radiother Oncol. 2026 Apr 29:111547. doi: 10.1016/j.radonc.2026.111547.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum